Aug 4 (Reuters) - Abeona Therapeutics Inc ABEO.O
* Abeona therapeutics announces european regulatory approval for phase 1/2 gene therapy clinical study for patients with sanfilippo syndrome type a (mps iiia) Further company coverage: ABEO.O
(Bengaluru Newsroom: +1-646-223-8780)